Harry Glorikian

Investment Stage

Focus Areas

About Investor

Harry Glorikian is a General Partner at Scientia Ventures (formerly New Ventures Funds, rebranded in 2020), targeting seed and Series A investments in Medical Devices, AgTech, Pharmaceuticals, and Health & Hospital Services, with checks between $3.0M and $10.0M. He is also a Research Affiliate at the MIT Media Lab, working on translating AI into practical decision tools for business and policy leaders. Before joining Scientia Ventures, he served as Entrepreneur in Residence at GE Ventures' New Business Creation Group, and previously co-founded and led Scientia Advisors, a strategic advisory firm for healthcare and life sciences companies, which was acquired by Precision for Medicine in 2012. He holds 4 US patents in telecommunications, serves on the board of GeneNews Ltd., and is a co-founder and advisory board member of DrawBridge Health. He holds an MBA from Boston University and a bachelor's degree from San Francisco State University. He is based in Boston, Massachusetts.